European Medicines Agency approves Dupixent for COPD
UK—The European Medicines Agency (EMA) has approved Dupixent (dupilumab) as an add-on maintenance...
Read MoreSelect Page
Jul 4, 2024
UK—The European Medicines Agency (EMA) has approved Dupixent (dupilumab) as an add-on maintenance...
Read MoreFeb 27, 2024
EUROPE—The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP)...
Read MoreOct 16, 2023
NETHERLANDS — The European Medicines Agency (EMA) announced on Friday that its drug advisory panel...
Read MoreAug 10, 2023
EUROPE — A regulatory upheaval has led pharmaceutical giant Novartis to withdraw its sickle cell...
Read MoreJul 24, 2023
GERMANY —Fresenius Kabi, a renowned global healthcare company specializing in biopharmaceuticals,...
Read MoreJul 24, 2023
BELGIUM — In a groundbreaking development, global pharmaceutical giant GSK has made a significant...
Read MoreJul 19, 2023
BELGIUM —The European Commission is proactively addressing potential shortages of key antibiotics...
Read MoreJul 11, 2023
NETHERLANDS — In response to reports of patients experiencing thoughts of suicide or self-injury,...
Read MoreApr 28, 2023
NETHERLANDS — The European Medicines Agency (EMA) has put GSK in a leading position in the...
Read MoreMar 15, 2023
NETHERLANDS — The European Medicines Agency (EMA) has urged doctors to prioritize the diabetes...
Read More